SCHEMBL6203845

SCHEMBL6203845

COCc1[c]cccc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA12 O43570 2/20 0.41
CA4 P22748 1/20 0.41
CA14 Q9ULX7 1/20 0.41
IDO1 P14902 3/20 0.37
ENPP2 Q13822 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 3/20 0.34
TP53 P04637 2/20 0.34
TSHR P16473 1/20 0.34
ADRA2B P18089 1/20 0.34
PTGS1 P23219 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64882 0.82 CA1 (0.42) CA1CA2CA7CA9CA12
SCHEMBL4586248 0.80 TAAR1 (0.41) CA1CA2CA7CA9CA12
SCHEMBL28069112 0.80 CA1 (0.41) CA1CA2CA7CA9CA12
SCHEMBL1526352 0.80 CA1 (0.41) CA1CA2CA7CA9CA12
SCHEMBL7838938 0.78 CA1 (0.39) CA1CA2CA7CA9CA12
SCHEMBL18091854 0.78 ACHE (0.36) CA1CA2CA7CA9CA12
SCHEMBL8468296 0.78 PDK2 (0.31) IDO1ALDH1A1TDP1KDM4EMAPT
SCHEMBL6282544 0.78 TSHR (0.31) TSHR
SCHEMBL8480841 0.77 ENPP2 (0.38) CA1CA2CA7CA9CA12
SCHEMBL18706055 0.77 HTR7 (0.42) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed